Tuoxin Pharmaceutical's latest announcement: not in Merck's qualified supplier directory system

Tuoxin Pharmaceutical issued a stock price change announcement that the company is not in Merck's qualified supplier directory system, the company has not signed any cooperation agreement with Merck, there is no cooperative relationship with it, and has not supplied uridine products to Merck. Uridine as a pharmaceutical intermediate production process is relatively mature, there is no high technical barriers and market access thresholds. From January to September 2020 and 2021, uridine products accounted for 11.02% and 9.63% of the company's operating income in each period, respectively, which had little impact on performance. Currently, the company has no urisine orders in hand.

The chairman of the company is Yang Xining. Mr. Yang Xining: Born in May 1962, Chinese nationality, no right of permanent residence abroad, master's degree, professor-level senior engineer, graduate degree in chemistry from Henan Normal University. From July 1983 to October 1988, he successively served as a teacher and director of the teaching and research department of Xihua Normal School in Henan Province. From October 1988 to July 1993, he successively served as a technician and workshop director of Xinxiang Organic Chemical Factory; From July 1993 to July 2001, he served as the director of Huafeng Fine Chemical Factory in Xinxiang City; From August 2001 to December 2011, he served as the chairman of Tuoxin Co., Ltd.; From August 2001 to July 2003 and from October 2009 to December 2011, he served as the general manager of Tuoxin Co., Ltd. Since August 2005, he has been the chairman of Xinxiang Pharmaceutical; From December 2011 to April 2020, he served as the general manager of the issuer; Since December 2011, he has served as the chairman of the board of directors of the issuer.

The above content is compiled by Securities Star based on public information, if you have any questions, please contact us.